Abstract
SHS investigation development is considered from the geographical and historical viewpoint. 3 stages are described. Within Stage 1 the work was carried out in the Department of the Institute of Chemical Physics in Chernogolovka where the scientific discovery had been made. At Stage 2 the interest to SHS arose in different cities and towns of the former USSR. Within Stage 3 SHS entered the international scene. Now SHS processes and products are being studied in more than 50 countries.
Abstract
Preeclampsia is a complication associated with pregnancy due to an
abnormal formation of placental blood vessels. Though the reason for occurrence is
unclear, recent studies have enabled us to understand the pathophysiology of the
condition, which has eventually improved its management. Multiple risk factors are
believed to contribute to poor placentation, which includes chronic hypertension,
antiphospholipid antibody syndrome, pre-gestational diabetes, chronic renal disease,
previous intrauterine growth restriction, and previous placental abruption.
Understanding preeclampsia at both biological and clinical levels is crucial for a proper
diagnosis. Abnormally elevated plasma levels of MMP7, sFlt1, sEng, PAPP-A, VEGF,
PIGF, activin A, and cell-free fetal DNA can serve as maternal markers for
preeclampsia. It has been widely accepted that these changes in the plasms levels
would complicate the natural course of pregnancies. Certain classical features like
hypertension and proteinuria still remain the best indicators of preeclampsia. An
abnormal hematological profile in preeclampsia is known to be associated with certain
coagulopathies, such as disseminated intravascular coagulation. In the current chapter,
we discuss both biological and clinical aspects of preeclampsia.
Keywords:
Biological aspects, Clinical aspects, Diagnosis and Management, Hematological complications, Preeclampsia.
Recommended Chapters
We recommend
Favorable 70-S: Investigation Branching 
Authors:Bentham Science Books